OTCMKTS:PBIO Pressure BioSciences (PBIO) Stock Forecast, Price & News $0.20 -0.01 (-4.76%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$0.18▼$0.2250-Day Range$0.19▼$0.5052-Week Range$0.18▼$2.20Volume70,645 shsAverage Volume46,167 shsMarket Capitalization$3.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest About Pressure BioSciences (OTCMKTS:PBIO) StockPressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Read More PBIO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBIO Stock News HeadlinesSeptember 22, 2023 | finance.yahoo.comPressure BioSciences’ Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective ImmediatelySeptember 21, 2023 | finanznachrichten.dePressure BioSciences Inc.: Pressure BioSciences Fulfillment of UltraShear Nano-CBD Orders is Underway; Customer Shipments Begin First Week of OctoberSeptember 28, 2023 | Porter and Company (Ad)Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI"If this tech goes mainstream, it could destroy the oil and gas industry, the clean energy sector, and the billionaires who profit from it…September 21, 2023 | bbc.comMeditate to beat stress blood pressure, say guidelinesSeptember 21, 2023 | americanbankingnews.comPressure BioSciences (OTCMKTS:PBIO) Stock Price Passes Below 200 Day Moving Average of $0.79September 8, 2023 | finance.yahoo.comPressure BioSciences’ BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. OrganizationAugust 30, 2023 | finance.yahoo.comPressure BioSciences Provides Second Progress Report on UltraShear Nano-CBD Launch and Commercialization Program "Drive to 420!"August 22, 2023 | finance.yahoo.comPressure BioSciences, Inc. Reports Q2 2023 Financial Results, Provides Business Update, and Offers Guidance for 2nd Half 2023September 28, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.August 21, 2023 | investing.comPressure Biosciences (PBIO) Earnings Dates & ReportsAugust 17, 2023 | finance.yahoo.comPressure BioSciences Invites Interested Investors to Attend a Webinar on the Health and Wellness Marvels of PBIO's Revolutionary UltraShear PlatformAugust 11, 2023 | finance.yahoo.comNew to The Street Announces its Six Corporate Guests TV Interviews; Broadcastings on Newsmax and The FOX Business Network, Airings Start on Saturday, August 12, 2023, at 3:30 PM ETAugust 9, 2023 | finanznachrichten.dePressure BioSciences Inc.: Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD OrdersAugust 9, 2023 | finance.yahoo.comPressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD OrdersJuly 27, 2023 | finance.yahoo.comPressure BioSciences and Master Distributor Canopy CBD Farms Announce Major Increase in UltraShear Nanoemulsion Platform PipelineJuly 25, 2023 | benzinga.comCBD To Extend Shelf-Life Of Fresh Produce? This Company Is Working On ItJuly 25, 2023 | finance.yahoo.comPressure BioSciences Launches Program to Evaluate Company's Patented UltraShear Process in Breakthrough Application to Extend Shelf-Life of Fresh ProduceJuly 17, 2023 | finance.yahoo.comPressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and PartneringJuly 10, 2023 | finance.yahoo.comPressure BioSciences Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Crème de CannaJuly 5, 2023 | finance.yahoo.comPressure BioSciences Announces Agreement with Somalab Int’l for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness ProductsJune 27, 2023 | finance.yahoo.comThird Round of Consumer Testing Strongly Validates Rapid Absorption and Effectiveness of Pressure BioSciences UltraShear Processed Nano-THC Oral SprayJune 13, 2023 | finance.yahoo.comPressure BioSciences Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other ProductsJune 2, 2023 | ca.finance.yahoo.comNew to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard AdsJune 1, 2023 | finance.yahoo.comNew to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard AdsJune 1, 2023 | finance.yahoo.comPressure BioSciences Updates Forecast with Six Key Goals for June 2023 with Expected Multi-Million Dollar Growth Increments in FY 2023 and BeyondMay 22, 2023 | finance.yahoo.comPressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear ProcessingMay 17, 2023 | marketwatch.comInvestorNewsBreaks - Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023See More Headlines Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PBIO Company Calendar Last Earnings8/21/2023Today9/28/2023Next Earnings (Estimated)11/20/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Analytical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PBIO CUSIPN/A CIK830656 Webwww.pressurebiosciences.com Phone508-230-1828Fax508-230-1829Employees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,080,000.00 Net Margins-1,132.78% Pretax Margin-1,132.83% Return on EquityN/A Return on Assets-1,038.95% Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.02 Sales & Book Value Annual Sales$1.73 million Price / Sales2.25 Cash FlowN/A Price / Cash FlowN/A Book Value($2.56) per share Price / Book-0.08Miscellaneous Outstanding Shares19,456,000Free Float17,413,000Market Cap$3.89 million OptionableNot Optionable Beta0.67 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Richard T. Schumacher (Age 73)Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director Comp: $320.54kDr. Alexander V. Lazarev Ph.D. (Age 58)Chief Science Officer Comp: $202.27kDr. Edmund Y. Ting Ph.D. (Age 68)Sc.D. Ph.D., Sr. VP of Engineering Comp: $215.16kJohn B. HollisterDirector of Sales & MarketingKey CompetitorsPrecipioNASDAQ:PRPOTalis BiomedicalNASDAQ:TLISPalisade BioNASDAQ:PALIBioceptNASDAQ:BIOCNexien BioPharmaOTCMKTS:NXENView All Competitors PBIO Stock - Frequently Asked Questions How have PBIO shares performed in 2023? Pressure BioSciences' stock was trading at $1.30 at the beginning of 2023. Since then, PBIO shares have decreased by 84.6% and is now trading at $0.1999. View the best growth stocks for 2023 here. Are investors shorting Pressure BioSciences? Pressure BioSciences saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 100 shares, a decline of 98.4% from the August 31st total of 6,200 shares. Based on an average daily trading volume, of 195,100 shares, the days-to-cover ratio is currently 0.0 days. View Pressure BioSciences' Short Interest. When is Pressure BioSciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023. View our PBIO earnings forecast. How were Pressure BioSciences' earnings last quarter? Pressure BioSciences, Inc. (OTCMKTS:PBIO) released its quarterly earnings results on Monday, August, 21st. The company reported ($0.57) earnings per share (EPS) for the quarter. The company earned $0.51 million during the quarter. What other stocks do shareholders of Pressure BioSciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS). What is Pressure BioSciences' stock symbol? Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO." How do I buy shares of Pressure BioSciences? Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Pressure BioSciences' stock price today? One share of PBIO stock can currently be purchased for approximately $0.20. How much money does Pressure BioSciences make? Pressure BioSciences (OTCMKTS:PBIO) has a market capitalization of $3.89 million and generates $1.73 million in revenue each year. The company earns $-16,080,000.00 in net income (profit) each year or ($1.84) on an earnings per share basis. How can I contact Pressure BioSciences? Pressure BioSciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The official website for the company is www.pressurebiosciences.com. The company can be reached via phone at 508-230-1828, via email at ir@pressurebiosciences.com, or via fax at 508-230-1829. This page (OTCMKTS:PBIO) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.